2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol
C65H73FN18O3 — CID 164957954
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol
2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol (PubChem CID 164957954) has the molecular formula C65H73FN18O3 and a molecular weight of 1173.42 g/mol. Its IUPAC name is 2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol.
Molecular Properties
| Compound Name | 2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol |
|---|---|
| PubChem CID | 164957954 |
| Molecular Formula | C65H73FN18O3 |
| Molecular Weight | 1173.42 g/mol |
| Exact Mass | 1172.61 |
| IUPAC Name | 2-[6-[(3S,5R)-3,5-dimethylpiperidin-1-yl]pyridazin-3-yl]-5-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(7-fluoro-2-methylindazol-5-yl)pyridin-3-ol;2-[6-(3-ethylpiperidin-1-yl)pyridazin-3-yl]-5-(1H-pyrazol-4-yl)pyridin-3-ol |
| SMILES | CCC1CCCN(c2ccc(-c3ncc(-c4cc(F)c5nn(C)cc5c4)cc3O)nn2)C1.CCC1CCCN(c2ccc(-c3ncc(-c4cn[nH]c4)cc3O)nn2)C1.C[C@@H]1C[C@H](C)CN(c2ccc(-c3ncc(/C=C/c4cnn(C)c4)cc3O)nn2)C1 |
| InChI | InChI=1S/C24H25FN6O.C22H26N6O.C19H22N6O/c1-3-15-5-4-8-31(13-15)22-7-6-20(27-28-22)24-21(32)11-17(12-26-24)16-9-18-14-30(2)29-23(18)19(25)10-16;1-15-8-16(2)13-28(12-15)21-7-6-19(25-26-21)22-20(29)9-17(10-23-22)4-5-18-11-24-27(3)14-18;1-2-13-4-3-7-25(12-13)18-6-5-16(23-24-18)19-17(26)8-14(9-20-19)15-10-21-22-11-15/h6-7,9-12,14-15,32H,3-5,8,13H2,1-2H3;4-7,9-11,14-16,29H,8,12-13H2,1-3H3;5-6,8-11,13,26H,2-4,7,12H2,1H3,(H,21,22)/b;5-4+;/t;15-,16+; |
| InChIKey | BKWPROPLKHNPRT-SKLZZDGISA-N |
| XLogP | 11.45 |
| TPSA | 250.74 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1173.42 |
| LogP ≤ 5 | 11.45 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164957954 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.